EC Number |
Title |
Organism |
---|
1.14.14.154 | An overview of azoles targeting sterol 14?-demethylase for antileishmanial therapy |
Leishmania major |
1.14.14.154 | An overview of azoles targeting sterol 14?-demethylase for antileishmanial therapy |
Leishmania mexicana |
1.14.14.154 | An overview of azoles targeting sterol 14?-demethylase for antileishmanial therapy |
Leishmania infantum |
1.14.14.154 | Azole antifungal sensitivity of sterol 14alpha-demethylase (CYP51) and CYP5218 from Malassezia globosa |
Malassezia globosa |
1.14.14.154 | Azole antifungal sensitivity of sterol 14alpha-demethylase (CYP51) and CYP5218 from Malassezia globosa |
Malassezia globosa CBS 7966 |
1.14.14.154 | Design, synthesis and antifungal activity evaluation of new thiazolin-4-ones as potential lanosterol 14alpha-demethylase inhibitors |
Candida albicans SC5314 |
1.14.14.154 | Identification, modeling and ligand affinity of early deuterostome CYP51s, and functional characterization of recombinant zebrafish sterol 14alpha-demethylase |
Danio rerio |
1.14.14.154 | Nitric oxide stimulates cellular degradation of human CYP51A1, the highly conserved lanosterol 14alpha-demethylase |
Homo sapiens |
1.14.14.154 | Structural analyses of Candida albicans sterol 14alpha-demethylase complexed with azole drugs address the molecular basis of azole-mediated inhibition of fungal sterol biosynthesis |
Candida albicans |
1.14.14.154 | Structural and functional elucidation of yeast lanosterol 14alpha-demethylase in complex with agrochemical antifungals |
Saccharomyces cerevisiae |